We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$104B
AUM Growth
+$704M
Cap. Flow
-$915M
Cap. Flow %
-0.88%
Top 10 Hldgs %
14.25%
Holding
2,771
New
148
Increased
1,779
Reduced
566
Closed
77

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$191M
2
SCHW
Charles Schwab
SCHW
+$157M
3
PFE icon
Pfizer
PFE
+$139M
4
MMM icon
3M
MMM
+$131M
5
META icon
Meta Platforms (Facebook)
META
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 17.28%
2 Financials 14.69%
3 Technology 14.25%
4 Consumer Discretionary 9.55%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JKHY icon
1101
Jack Henry & Associates
JKHY
$11.1B
$3.68M ﹤0.01%
56,828
-17,667
-24% -$1.17M
XLRN
1102
DELISTED
Acceleron Pharma
XLRN
$3.66M ﹤0.01%
115,792
+5,092
+5% +$164K
NRF
1103
DELISTED
NorthStar Realty Finance Corp.
NRF
$3.66M ﹤0.01%
115,189
+29,415
+34% +$1.06M
FR icon
1104
First Industrial Realty Trust
FR
$8.5B
$3.66M ﹤0.01%
195,380
+21,228
+12% +$424K
ACM icon
1105
Aecom
ACM
$9.74B
$3.65M ﹤0.01%
110,452
+9,100
+9% +$300K
RGLD icon
1106
Royal Gold
RGLD
$17.5B
$3.59M ﹤0.01%
58,265
+5,300
+10% +$340K
BRO icon
1107
Brown & Brown
BRO
$23.8B
$3.59M ﹤0.01%
218,394
+17,800
+9% +$291K
INFA
1108
DELISTED
INFORMATICA CORP
INFA
$3.59M ﹤0.01%
73,991
+8,940
+14% +$430K
XHR
1109
Xenia Hotels & Resorts
XHR
$1.89B
$3.58M ﹤0.01%
+164,420
New +$3.74M
OC icon
1110
Owens Corning
OC
$11.7B
$3.57M ﹤0.01%
86,655
+1,783
+2% +$73.1K
PBR icon
1111
Petrobras
PBR
$121B
$3.57M ﹤0.01%
394,245
-54,600
-12% -$489K
ESL
1112
DELISTED
Esterline Technologies
ESL
$3.57M ﹤0.01%
37,407
+3,132
+9% +$335K
BRCD
1113
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$3.56M ﹤0.01%
300,127
+19,700
+7% +$239K
QIHU
1114
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
$3.56M ﹤0.01%
52,600
-1,500
-3% -$90.5K
SXT icon
1115
Sensient Technologies
SXT
$5.41B
$3.56M ﹤0.01%
52,077
+15,556
+43% +$1.06M
RS icon
1116
Reliance Steel & Aluminium
RS
$21.2B
$3.55M ﹤0.01%
58,699
+3,700
+7% +$234K
LNN icon
1117
Lindsay Corp
LNN
$1.2B
$3.54M ﹤0.01%
40,237
-8,766
-18% -$696K
MUSA icon
1118
Murphy USA
MUSA
$10.9B
$3.54M ﹤0.01%
63,359
+14,421
+29% +$905K
CIB icon
1119
Grupo Cibest SA
CIB
$21.4B
$3.53M ﹤0.01%
82,045
-9,600
-10% -$413K
TCBI icon
1120
Texas Capital Bancshares
TCBI
$4.41B
$3.52M ﹤0.01%
56,573
-17,403
-24% -$953K
MYGN icon
1121
Myriad Genetics
MYGN
$303M
$3.52M ﹤0.01%
103,551
-24,949
-19% -$848K
WR
1122
DELISTED
Westar Energy Inc
WR
$3.51M ﹤0.01%
102,581
+9,200
+10% +$336K
PF
1123
DELISTED
Pinnacle Foods, Inc.
PF
$3.51M ﹤0.01%
77,081
+19,209
+33% +$812K
HHH icon
1124
Howard Hughes
HHH
$3.91B
$3.49M ﹤0.01%
25,535
+1,888
+8% +$269K
WKC icon
1125
World Kinect Corp
WKC
$2B
$3.49M ﹤0.01%
72,772
+5,000
+7% +$262K

Similar funds

UBS AM's Q2 2015 Portfolio in Review

As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
  • UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
  • UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
  • UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
  • UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
  • UBS AM opened 148 new positions and closed 77 in Q2 2015.
  • UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.

Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.